These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 38956031)
1. Factors underlying the neurofunctional domains of the Addictions Neuroclinical Assessment assessed by a standardized neurocognitive battery. Gunawan T; Luk JW; Schwandt ML; Kwako LE; Vinson T; Horneffer Y; George DT; Koob GF; Ramchandani VA; Diazgranados N; Goldman D Transl Psychiatry; 2024 Jul; 14(1):271. PubMed ID: 38956031 [TBL] [Abstract][Full Text] [Related]
2. The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment-Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance. Votaw VR; Pearson MR; Stein E; Witkiewitz K Alcohol Clin Exp Res; 2020 Mar; 44(3):679-688. PubMed ID: 31957027 [TBL] [Abstract][Full Text] [Related]
3. Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine. Nieto SJ; Ray LA Behav Brain Res; 2022 Jun; 427():113876. PubMed ID: 35378110 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers. Nieto SJ; Grodin EN; Green R; Ray LA Drug Alcohol Depend; 2021 Apr; 221():108603. PubMed ID: 33618192 [TBL] [Abstract][Full Text] [Related]
5. Neural correlates of the addictions neuroclinical assessment (ANA) incentive salience factor among individuals with alcohol use disorder. Nieto SJ; Grodin EN; Ray LA Behav Brain Res; 2024 Apr; 464():114926. PubMed ID: 38431152 [TBL] [Abstract][Full Text] [Related]
6. Validity and measurement invariance of the Addictions Neuroclinical Assessment incentive salience domain among treatment-seekers with alcohol use disorder. Stein ER; Votaw VR; Swan JE; Witkiewitz K J Subst Abuse Treat; 2021 Mar; 122():108227. PubMed ID: 33509416 [TBL] [Abstract][Full Text] [Related]
7. Neurofunctional Domains Derived From Deep Behavioral Phenotyping in Alcohol Use Disorder. Kwako LE; Schwandt ML; Ramchandani VA; Diazgranados N; Koob GF; Volkow ND; Blanco C; Goldman D Am J Psychiatry; 2019 Sep; 176(9):744-753. PubMed ID: 30606047 [TBL] [Abstract][Full Text] [Related]
8. Neural correlates of alcohol use disorder severity among nontreatment-seeking heavy drinkers: An examination of the incentive salience and negative emotionality domains of the alcohol and addiction research domain criteria. Al-Khalil K; Vakamudi K; Witkiewitz K; Claus ED Alcohol Clin Exp Res; 2021 Jun; 45(6):1200-1214. PubMed ID: 33864389 [TBL] [Abstract][Full Text] [Related]
9. Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use. Votaw VR; Boness CL; Stein ER; Watts AL; Sher KJ; Witkiewitz K Exp Clin Psychopharmacol; 2024 Feb; 32(1):68-83. PubMed ID: 37227882 [TBL] [Abstract][Full Text] [Related]
10. Addictions NeuroImaging Assessment (ANIA): Towards an integrative framework for alcohol use disorder. Voon V; Grodin E; Mandali A; Morris L; Doñamayor N; Weidacker K; Kwako L; Goldman D; Koob GF; Momenan R Neurosci Biobehav Rev; 2020 Jun; 113():492-506. PubMed ID: 32298710 [TBL] [Abstract][Full Text] [Related]
11. A Longitudinal Mediation Model of Negative Emotionality, Coping Motives and Drinking Intensity Among Individuals Receiving Community Treatment for Alcohol Use Disorder. Votaw VR; Stein ER; Witkiewitz K Alcohol Alcohol; 2021 Aug; 56(5):573-580. PubMed ID: 33778864 [TBL] [Abstract][Full Text] [Related]
13. Early life stress is associated with greater negative emotionality and peripheral inflammation in alcohol use disorder. Kirsch DE; Grodin EN; Nieto SJ; Kady A; Ray LA Neuropsychopharmacology; 2024 Oct; 49(11):1719-1728. PubMed ID: 38740901 [TBL] [Abstract][Full Text] [Related]
15. Mapping data-driven individualized neurobehavioral phenotypes in heavy alcohol drinkers. DeMartini KS; Gueorguieva R; Pearlson G; Krishnan-Sarin S; Anticevic A; Ji LJ; Krystal JH; O'Malley SS Alcohol Clin Exp Res; 2021 Apr; 45(4):841-853. PubMed ID: 33605439 [TBL] [Abstract][Full Text] [Related]
16. Relationship of negative emotionality, NIAAA recovery, and 3- and 6-month drinking outcomes among adults in treatment for alcohol use disorder. Linn BK; Zhao J; Stasiewicz PR; LaBarre C; Wilding GE; Bradizza CM Drug Alcohol Depend; 2023 Jan; 242():109695. PubMed ID: 36442440 [TBL] [Abstract][Full Text] [Related]
17. Sex, executive function, and prospective memory regulate the chain-mediation pathway of alcohol use and impulsivity. Duan F; Xia L; Li J; Li X; Zhou Y; Luo H; Wang Z; Song X; Wang J; Chen J; Wang Y; Zhang J; Zhang X; Jiao D Front Public Health; 2023; 11():1292422. PubMed ID: 38174071 [TBL] [Abstract][Full Text] [Related]
18. Neurocognition and inhibitory control in polysubstance use disorders: Comparison with alcohol use disorders and changes with abstinence. Schmidt TP; Pennington DL; Cardoos SL; Durazzo TC; Meyerhoff DJ J Clin Exp Neuropsychol; 2017 Feb; 39(1):22-34. PubMed ID: 27690739 [TBL] [Abstract][Full Text] [Related]
19. Family History of Alcohol Abuse Associated with Higher Impulsivity in Patients with Alcohol Use Disorder: A Multisite Study. Khemiri L; Kaag AM; Joos L; Dom G; Franck J; Goudriaan AE; Jayaram-Lindström N Eur Addict Res; 2020; 26(2):85-95. PubMed ID: 31940649 [TBL] [Abstract][Full Text] [Related]
20. Impulsive Decision Making in Young Adult Social Drinkers and Detoxified Alcohol-Dependent Patients: A Cross-Sectional and Longitudinal Study. Bernhardt N; Nebe S; Pooseh S; Sebold M; Sommer C; Birkenstock J; Zimmermann US; Heinz A; Smolka MN Alcohol Clin Exp Res; 2017 Oct; 41(10):1794-1807. PubMed ID: 28815629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]